TTM
−$37.60
YoY change
-47.5%
5Y CAGR
—
Peak year (2019)
−$22.50
Latest annual
−$50.83
EPS (Diluted) history chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: −$50.83
EPS (Diluted) growth chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: -47.5%
EPS (Diluted) history table for Spruce Biosciences (SPRB) from 2018 to 2025
| 2025 | −$50.83 | -47.5% | +$45.92 | ||
| 2024 | −$96.75 | +4.0% | −$3.75 | ||
| 2023 | −$93.00 | +29.2% | −$21.00 | ||
| 2022 | −$72.00 | +5.5% | −$3.75 | ||
| 2021 | −$68.25 | +40.0% | −$19.50 | ||
| 2020 | −$48.75 | +116.7% | −$26.25 | ||
| 2019 | −$22.50 | -95.3% | +$461.25 | ||
| 2018 | −$483.75 | — | — |
- 2025−$50.83-47.5%
- 2024−$96.75+4.0%
- 2023−$93.00+29.2%
- 2022−$72.00+5.5%
- 2021−$68.25+40.0%
- 2020−$48.75+116.7%
- 2019−$22.50-95.3%
- 2018−$483.75—
EPS (Diluted) values are taken from Spruce Biosciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Spruce Biosciences (SPRB)
According to Spruce Biosciences's latest reported financial statements, the company's current diluted EPS (TTM) is −$37.60. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted EPS for Spruce Biosciences (SPRB) came in at −$50.83 – plunged 47.5% year-over-year.
Across the available history, diluted EPS reached its high of −$22.50 in 2019 and its low of −$483.75 in 2018.
Spruce Biosciences EPS (Diluted) by Year
Spruce Biosciences EPS (Diluted) 2025: −$50.83
Spruce Biosciences diluted EPS in 2025 was −$50.83, plunged 47.5% below 2024.
Spruce Biosciences EPS (Diluted) 2024: −$96.75
2024's diluted EPS for Spruce Biosciences came in at −$96.75, edged up 4.0% from 2023.
Spruce Biosciences EPS (Diluted) 2023: −$93.00
Spruce Biosciences posted diluted EPS of −$93.00 in 2023, grew 29.2% from 2022.
Spruce Biosciences EPS (Diluted) 2022: −$72.00
In 2022, Spruce Biosciences reported diluted EPS of −$72.00, grew 5.5% from 2021.
Spruce Biosciences EPS (Diluted) 2021: −$68.25
Spruce Biosciences diluted EPS in 2021 was −$68.25.
See more financial history for Spruce Biosciences (SPRB). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation